Deciphera completes enrolment in Phase III trial of DCC-2618
Deciphera Pharmaceuticals has completed enrolment in the Phase III INVICTUS clinical trial to examine the safety, tolerability and efficacy of…
Deciphera DCC-2618 gastrointestinal stromal tumour